Global

Did Cyclacel Pharmaceuticals, (NASDAQ:CYCC) Trigger A Hold Signal?

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) fell by -4.53% in the last day from $3.09 to $2.95 and has now fallen 4 consecutive sessions. The price has fallen in 7 of the last 10 days and is down by -20.91% over the same course of time. Volume has increased in the last day by 0.56 million shares, but on a weak note. This is may be an early warning and the risk will be increased slightly for the next couple of days. In total, 1.53 M shares exchanged hands for about $4.50 million.

Inside CYCC’s Recent Trend

Short-term traders are anticipated to see a retreat of -36.67% over the course of a quarter and, with 90% chance the price will be floating in the range of $1.87 and $2.44 in this timeframe.

Cyclacel Pharmaceuticals, Inc. Technical Signals



CYCC has witnessed its long term and short term MA triggering a sell signal. Many traders watch for long-term averages to cross above short-term averages to signal the beginning of a downtrend. Upon corrections, the price will meet resistance from the averages between $3.36 and $3.99. A buy signal will be generated if it crosses above any of these levels. Its pivot point high generated sell signal on Thursday July 13, 2017, which calls for additional declines until the stock forms a new pivot point low, as this could be a buying opportunity. Volume up and price depreciating is getting our attention as this movement is seen as bearish sign.

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Support And Resistance Levels

There is no support from accumulated volume below today’s level and given the right condition the stock may perform very badly in the next couple of days. In case of gains, the next resistance from accumulated volume will not be far away from today’s level at $3.09, $3.65 and $3.45.




Accumulated volume is going to prevent the price from rising further at $3.09 and this action will lead the price to take a temporary pause or stay muted for a few days.

Cyclacel Pharmaceuticals, Inc. (CYCC) Risk Assessment

A volatility based measure Bollinger Bands suggests this stock poses high risk. In the most recent session, the stock price hovered around $0.33 between high and low, or 11.22%. The average volatility for the past week stood at 10.34%.

Cyclacel Pharmaceuticals is overbought on RSI14 (14). Some stocks may go long and hard while being overbought on RSI, but overbought increases the general risk as higher volatility could be expected, and at some level the stock will have a reaction back to gain new strength.

 

Previous ArticleNext Article

Related Post

CSRA Inc. (CSRA) vs. ServiceNow, Inc. (NOW): Break... CSRA Inc. (NYSE:CSRA) and ServiceNow, Inc. (NYSE:NOW) are the two most active stocks in the Information Technology Services industry based on today’s ...
The Fundamental Facts on CVS Health Corporation (C... It is interesting to note that CVS Health Corporation (NYSE:CVS) is active and made a solid movement in the last trading day. Now trading with a marke...
It’s worth it to have a look at United State... United States Steel Corporation (NYSE:X) is on our radar right now but there could still be some opportunities on the horizon. Now trading with a mark...
Which of 2 stocks would appeal to long-term invest... The shares of Cisco Systems, Inc. have increased by more than 25.45% this year alone. The shares recently went down by -0.13% or -$0.05 and now trades...
Time Warner Inc. (TWX): Signals from Technical Per... Time Warner Inc. (NYSE:TWX) fell by -0.20% in Wednesday’s trading session from $98.49 to $98.29 and has now fallen 4 consecutive sessions. The price h...

Leave a Reply

Your email address will not be published. Required fields are marked *